Evaluation of the Impact of Lung Ultrasound on Mortality and Rehospitalization in Patients Admitted to the Emergency Department With Dyspnea
NCT ID: NCT05787665
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
385 participants
OBSERVATIONAL
2023-06-16
2025-11-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Multiple etiologies, as well as poor performance of clinical examination and chest radiography, lead to a diagnostic error rate of nearly 30% at the end of emergency department care. These diagnostic errors lead to rehospitalization and an excess mortality rate of more than 50% compared to patients with a correct initial diagnosis, which is explained in particular by the use of inappropriate therapies.
Lung ultrasound is a rapid, non-irradiating, non-invasive, inexpensive, reproducible imaging test that can be used at the bedside. It has a better diagnostic performance than chest radiography, commonly performed in emergency departments.The immediate benefit of lung ultrasound for the most common diagnoses in emergency medicine has already been demonstrated.
From an organizational point of view, a few studies have shown a benefit of lung ultrasound in reducing the time spent in emergency departments and the number of additional examinations necessary for the final diagnosis. However, there is no data in the literature on the longer term impact of its use in the emergency department.
The primary objective is to evaluate the impact of performing lung ultrasound in terms of 3-month mortality and rehospitalization as part of the diagnostic process for patients admitted to the emergency department with dyspnea.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Impact of Pleuropulmonary Ultrasound on the Diagnosis of Dyspnea
NCT07104578
Lung Ultrasound for Acute Dyspnea in Emergency Department
NCT01287429
Value of Diaphragmatic Motion Measurement at Ultrasonography to Predict Poor Prognosis in Emergency Department Patients With Acute Respiratory Failure
NCT04119505
Added Diagnostic Value of Point of Care Ultrasound in Acute Dyspnea
NCT05782478
Prevalence and Kinetics of Diaphragmatic Dysfunction in Elderly Patients With Acute Respiratory Distress
NCT04520815
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
With Lung Ultrasonography
Patient who meet inclusions criteria, and which lung ultrasonography were performed during their medical care in Emergency Department
phone call at 3 months
patients will be called at 3 months to know if they are alive and to know if they have been rehospitalized
Without Lung Ultrasonography
Patient who meet inclusions criteria, and which lung ultrasonography were not performed during their medical care in Emergency Department.
phone call at 3 months
patients will be called at 3 months to know if they are alive and to know if they have been rehospitalized
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
phone call at 3 months
patients will be called at 3 months to know if they are alive and to know if they have been rehospitalized
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission to the emergency department with dyspnea defined by:
The functional sign of dyspnea experienced by the patient; Or a clinical sign of respiratory distress.
\- Non-opposition of the patient or patient's family if the patient isn't able
Exclusion Criteria
* Patient being on palliative care;
* Patient with criteria for initial resuscitation with admission to a critical care unit;
* Pregnant women, women in labour or nursing mothers;
* Persons deprived of liberty by judicial or administrative decision;
* Persons under psychiatric care;
* Persons admitted to a health or social institution for purposes other than research;
* Persons of full age subject to a legal protection measure (guardianship, curatorship);
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
JULIA MORERE, MD
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Edouard-Herriot - Emergency Department
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A00177-38
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL23_0002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.